Urinary morbidity after 125I brachytherapy of the prostate.

Urinary morbidity after 125I brachytherapy of the prostate.

Bibliographic Details
Main Authors:	Henderson, A, Bott, SR, Sooriakumaran, P, Laing, R, Langley, SE
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy.
by: Khaksar, S, et al.
Published: (2006)

Brachytherapy: the surgeon's perspective.
by: Henderson, A, et al.
Published: (2004)

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
by: Kenta Onishi, et al.
Published: (2019-01-01)

Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
by: Nobes, J, et al.
Published: (2008)

Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
by: Nobes, J, et al.
Published: (2008)

COX-2 inhibition: a possible role in the management of prostate cancer?
by: Sooriakumaran, P, et al.
Published: (2007)

Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer.
by: Sooriakumaran, P, et al.
Published: (2005)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
by: Philipp Maletzki, et al.
Published: (2018-06-01)

Changes in lower urinary tract symptoms after prostate brachytherapy
by: Bruce L. Jacobs, et al.
Published: (2011-09-01)

A novel method of obtaining prostate tissue for gene expression profiling.
by: Sooriakumaran, P, et al.
Published: (2009)

Comparative cost-effectiveness of focal and total salvage 125 I brachytherapy for recurrent prostate cancer after primary radiotherapy
by: Max Peters, et al.
Published: (2016-12-01)

Personalized radioprotection in tumor patients after 125I seed brachytherapy
by: Jianmin Li, et al.
Published: (2021-09-01)

Radioactive seed migration after prostate brachytherapy with Iodine-125 using loose seeds versus stranded seeds
by: Carlos A. S. Franca, et al.
Published: (2009-10-01)

Brachytherapy Using I-125 Implant in the Treatment of Localized Prostate Cancer: KFSYSCC Initial Experience
by: Yu-Hung Lin, et al.
Published: (2015-06-01)

A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
by: Sooriakumaran, P, et al.
Published: (2009)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
by: Tomoyuki Makino, et al.
Published: (2016-12-01)

Application of 125 I brachytherapy to adenoid cystic carcinoma
by: Kai Sun, et al.
Published: (2024-02-01)

Iodine-125 brachytherapy and robotic stereotactic radiotherapy — treatment options for patients with localized prostate cancer
by: E. A. Kiprijanov, et al.
Published: (2021-12-01)

Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma
by: Sean T. Berkowitz, et al.
Published: (2022-06-01)

Geant 4 Monte Carlo simulation for I-125 brachytherapy
by: Jie Liu, et al.
Published: (2024-07-01)

Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose <sup>125</sup>I seeds
by: Shiraishi Yutaka, et al.
Published: (2011-10-01)

Treatment planning considerations for 125I eye plaque brachytherapy
by: David Miguel, et al.
Published: (2019-06-01)

Advances of 125I Radioactive Particle Chain Intracavitary Brachytherapy
by: YAO Yuan, et al.
Published: (2019-10-01)

I125 brachytherapy for central adenoid cystic carcinoma of the mandible
by: Li Wang, et al.
Published: (2018-06-01)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
by: Thomas Brun, et al.
Published: (2018-10-01)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
by: Rui Fang, et al.
Published: (2021-03-01)

A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
by: Sooriakumaran, P, et al.
Published: (2009)

A blinded, randomised controlled trial of neo-adjuvant Celecoxib in patients with localised prostate cancer
by: Sooriakumaran, P, et al.
Published: (2007)

Corrigendum to Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After 125I Interstitial Brachytherapy
Published: (2020-07-01)

Determination of the Dosimetric Characteristics of BATAN’s 125I Source for Brachytherapy: An Experimental Study
by: K.Y.P. Sandy, et al.
Published: (2018-08-01)

The Progress of Absolute Measurement Methods of the Intensity of 125I Brachytherapy Seeds
by: GAO Yan;LIU Mingyang;REN Chunxia;WANG Nian;FU Kexin;CHEN Yiting
Published: (2023-02-01)

Permanent <sup>125</sup>I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
by: Mazeron Renaud, et al.
Published: (2012-03-01)

Reduced blood flow by laser speckle flowgraphy after 125I-plaque brachytherapy for uveal melanoma
by: Michelle R. Tamplin, et al.
Published: (2022-06-01)

First brachytherapy treatment of prostate cancer in Nigeria using low dose rate radioactive iodine 125
by: Oludare Folajimi Adeyemi, et al.
Published: (2020-12-01)

Iodine-125 brachytherapy for brain tumours - a review
by: Schwarz Silke B, et al.
Published: (2012-03-01)

The Effect of Scattering from Leg Region on Organ Doses in Prostate Brachytherapy for 103Pd, 125I and 131Cs Seeds
by: Seyed Milad Vahabi, et al.
Published: (2016-09-01)

Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
by: Makoto Nakiri, et al.
Published: (2022-07-01)

Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with <sup>125</sup>I free seeds
by: Asakura Hirotaka, et al.
Published: (2010-09-01)

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma
by: Fu-Lei Gao, et al.
Published: (2022-06-01)

Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma
by: Hiroto Horiguchi, et al.
Published: (2014-08-01)